On Assignment (ASGN) was Initiated by Deutsche Bank to “Buy” and the brokerage firm has set the Price Target at $44. Deutsche Bank advised their investors in a research report released on Aug 18, 2016.
On the company’s financial health, On Assignment reported $0.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.78. The company had revenue of $608.10 million for the quarter, compared to analysts expectations of $600.36 million. The company’s revenue was up 25.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.61 EPS.
On Assignment closed down -0.07 points or -0.19% at $36.17 with 1,90,460 shares getting traded on Wednesday. Post opening the session at $36.18, the shares hit an intraday low of $35.83 and an intraday high of $36.55 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
In a different news, on Jun 15, 2016, Michael Mcgowan (COO, OAI; Pres, OGR) sold 8,000 shares at $37.01 per share price. According to the SEC, on Apr 19, 2016, Peter T Dameris (President & CEO) sold 140,000 shares at $46.89 per share price. On Dec 11, 2015, William E Brock (director) sold 6,523 shares at $45.88 per share price, according to the Form-4 filing with the securities and exchange commission.
On Assignment Inc. is a global provider of professionals in the information technology (IT) engineering and life sciences sectors. The Company matches people into positions for contract contract-to-hire and direct hire assignments. Its operating segments include Apex Oxford and Life Sciences Europe. The Apex Segment provides information technology and scientific staffing professionals for contract contract-to-hire and permanent placement positions. The Oxford Segment provides contract and direct placement services of information technology and engineering professionals in specialized information technology software and hardware engineering and mechanical electrical validation and telecommunications engineering fields. The Life Sciences Europe Segment provides locally-based contract life science professionals to clients in the biotechnology pharmaceutical food and beverage medical device personal care chemical automotive educational and environmental industries.